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Abstract
Invasive non-typhoidal Salmonella are a common cause of invasive disease in immuno-compromised individuals
and in children. Multi-drug resistance poses challenges to disease control, with a critical need for effective vaccines.
Flagellin is an attractive vaccine candidate due to surface exposure and high epitope copy number, but its potential
as a target for opsonophacytic antibodies is unclear.
We examined the effect of targeting flagella with different classes of IgG on the interaction between Salmonella
Typhimurium and a human phagocyte-like cell line, THP-1. We tagged the FliC flagellar protein with a foreign CD52
mimotope (TSSPSAD) and bacteria were opsonized with a panel of humanised CD52 antibodies with the same
antigen-binding V-region, but different constant regions. We found that IgG binding to flagella increases bacterial
phagocytosis and reduces viable intracellular bacterial numbers. Opsonisation with IgG3, followed by IgG1, IgG4,
and IgG2, resulted in the highest level of bacterial uptake and in the highest reduction in the intracellular load of
viable bacteria. Taken together, our data provide proof-of-principle evidence that targeting flagella with antibodies
can increase the antibacterial function of host cells, with IgG3 being the most potent subclass. These data will assist
the rational design of urgently needed, optimised vaccines against iNTS disease.
Keywords: Flagella; Antibody; Phagocytosis; IgG subclasses;
Opsonisation
Introduction
Non-typhoidal Salmonella (NTS) disease is a major public health
burden. It usually manifest as self-limiting gastroenteritis in humans
[1]. However, in immuno-compromised individuals (such as malaria
and HIV-infected patients) and children especially in developing
countries, it predominantly manifests in an invasive NTS (iNTS)
disease with bacteremia [2-4], which is most commonly caused by
Salmonella enterica serovars Typhimurium and Enteritidis. The case
fatality of iNTS is 20-25% in children [3] and up to 47% in HIV-
infected adults [5]. Increased drug resistance and emergence of new
multi-drug resistant S. enterica strains has made iNTS disease difficult
to manage [6-8]. There is very broad consensus that vaccines against
iNTS are urgently needed. Several classes of vaccines against iNTS (e.g.
live attenuated, polysaccharide, conjugates) are currently being
considered, but no vaccine is currently licensed for use in humans [9].
Antibodies and phagocytes are essential effectors that mediate
protection against invasive salmonellosis [10-15]. Salmonella growth in
the tissues is paralleled by the spread of the microorganisms
throughout the body via the extracellular space and by blood from
established infection foci to new sites [16]. Cytokine-driven host
responses recruit phagocytes to multicellular pathological lesions,
trapping the bacteria within discrete foci of infection [12-14,17], where
the antimicrobial action of reactive oxygen and nitrogen species (ROS
and RNS) restricts intracellular growth [17-20]. During their
extracellular dispersion, Salmonella become vulnerable to antibodies
and complement that opsonise the bacteria and target them to
receptors on the surface of phagocytes, increasing the ROS-dependent
antimicrobial functions of the host cells [12-15,17,21-23].
Infection with S. enterica induces production of antibodies against
various bacterial targets such as flagellar proteins, outer membrane
proteins, lipopolysaccharide (LPS), heat shock proteins and fimbriae
[24-28]. However, the full spectrum of the antigen specificity of the
protective antibody response against invasive salmonelloses is still
unclear.
The surface exposed FliC flagellin protein is involved in bacterial
invasion as illustrated by reduced invasiveness of FliC-deficient
mutants in vitro [29], and contributes to bacterial virulence and
protection in murine models of the disease [30-33]. Therefore, flagellin
may be an attractive vaccine candidate. Flagellin could also serve as a
carrier and an adjuvant. The flagellum is a polymer of flagellin and
hence acts as a multivalent antigen expressing multiple copies of the
epitope. Flagella have been used as a carrier for foreign antigens and
have shown efficient antibody induction to both the flagellin and
foreign epitopes [34-36]. Being surface exposed, both the flagellin and
the foreign epitopes are efficiently presented to the immune system.
The flagellin protein interacts with Toll-like receptor 5 (TLR-5), which
activates NFκB [37]. This leads to the induction of a pro-inflammatory
immune response, giving the flagella its adjuvanticity.
Given the increasing interest in the use of flagella as an antigen
target and as a carrier [34-36, 38], we aimed to examine the potential
efficacy of targeting the FliC protein with antibodies to enhance
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phagocyte functions known to be essential for protective immunity
against Salmonella. We have previously shown that targeting the
surface-abundant OmpA protein with human IgGs can increase the
uptake and killing of bacteria by human phagocytic cells, the efficiency
of these functions depending both on the subclass of the IgG and the
FcR that is available for antibody binding [39]. Broadening the
repertoire of antigens to be included in future iNTS multicomponent
vaccines is desirable. Therefore, in the current study we used a
similarly robust experimental system, where we tagged flagella with the
CD52 mimotope (TSSPSAD) and then opsonised the bacteria with a
panel of humanised CD52 antibodies that share the same antigen-
binding V-region, but have constant regions of different subclasses.
Using this system, we investigated whether targeting flagella with
antibodies can mediate key phagocyte functions associated with host
resistance to infection, in particular phagocytosis and intracellular
bacterial killing.
Materials and Methods
Reagents and media
All reagents and media were obtained from Sigma-Aldrich, Poole,
UK unless stated otherwise.
Bacterial strains
S. Typhimurium LDV321 [40] is a non-motile derivative of parent
strain SL3261 [41], where fliC, fljA and fljB (but not the hin promoter)
are excised. We generated a green fluorescent protein (GFP)-
expressing derivative of SL3261 by inserting a DNA fragment that
consists of the gfp gene from Aequoria Victoria and a chloramphenicol
resistance cassette between pseudogenes malX and malY on the
chromosome by oligonucleotide-directed mutagenesis [42]. The DNA
fragment consisting of the gfp gene and the chloramphenicol
resistance cassette with 5’ and 3’ arms homologous to the DNA
flanking the pseudogenes was amplified by PCR using primer pair
MalXT (5'-CCG CAG GTT CAG TCG GTA AAA GAT GAA ATG
GTT GGC CTG ATG AAT ACC GTT CAG GCA TAA CCT GGG
GTA ATG ACT CTC TAG C-3') and MalYCam (5'-CTA CGT ACA
CCA TGT CCC GCG TCG GTC AAC TTC CTG TGA AAA ATC
GAA CAT ATC CCT TCC GAC GTC ATT TCT GCC ATT CAT
CC-3’). Underlined regions of the primers indicate sequences
complementary to the downstream region of the malX gene and
sequences complementary to the upstream region of the malY gene
respectively. To allow tagging of the flagella, we transformed GFP-
expressing S. Typhimurium LDV321 with a recombinant pFF408
[40,43]. The recombinant pFF408 was generated by inserting DNA
encoding a short peptide (TSSPSAD), which is a mimotope of the
human CD52 antigen, between unique XhoI and BglII restriction
enzyme sites at the central region of the fliC gene in the plasmid
pFF408 [43]. The fliC gene is under the native fliC promoter. To
generate the fragment consisting of the sequence encoding for the
TSSPSAD mimotope, we amplified a fragment upstream of the
insertion site in pFF408 using primer pair CDPCRF3 (5'-CAT GAT
TAC GAA TTC GTT ATC GGC-3’) and CDPCRR3 (5'-TTT TTT
CTC GAG ATC CGC GGA CGG GGA GGA GGT AGA TCT AGT
ACC ACC AAG ACC AGT AGC-3’). Underlined segment of the
CDPCRR3 primer encodes for the TSSPSAD mimotope, thereby
inserting the mimotope to the fragment. This fragment that consisted
of mimotope-encoding sequence was then inserted into pFF408 by
conventional ligation. The insertion of the gfp gene between malX and
malY genes and the insertion of the TSSPSAD mimotope-coding
sequence in the fliC gene were confirmed by standard sequencing.
Expression of GFP and the mimotope were verified by
immunofluorescence (see Supplementary Figure 1). We confirmed that
the insertion of the CD52 mimotope did not interfere with assembly of
the FliC flagella on the bacterial surface and the recombinant bacterial
strain was motile (see Supplementary Figure 2).
Figure 1: Bacterial uptake following infection of S. Typhimurium
opsonised with antibodies targeting the bacterial flagella. THP-1
cells were infected with S. Typhimurium opsonised with anti-
TSSPSAD antibodies or control IgG. The anti-TSSPSAD antibodies
were of different subclasses, either IgG1, IgG2, IgG3 or IgG4. (A)
Percentage of infected cells. The graph shows the percentages of
cells harbouring visible intracellular bacteria. Assay was performed
as three independent biological replicates (n=3), conducted in
duplicate. Each data point in the graph represents the mean of
duplicate for an individual experiment. The horizontal line in the
graph represents the mean percentage of infected cells. 450 host
cells were counted for each of the three independent set of
experiments. (B) Intracellular bacterial distribution. The graph
shows distributions of visible intracellular bacteria per infected cell,
which are expressed as the mean distributions from three
independent biological replicates. 450 host cells were counted for
each of the three independent set of experiments.
Cell culture
The human monocyte cell line THP-1 was grown in RPMI-1640
supplemented with 10% fetal calf serum, 2 mM L-glutamine, 0.05 mM
2-mercaptoethanol at 37ºC. Prior to bacterial infection, THP-1 cells
were grown in RPMI-1640 supplemented with 10% Nu serum (VWR),
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2 mM L-glutamine, 0.05 mM 2-mercaptoethanol for 22 days, followed
by an incubation with 100 U/ml rIFNγ for 48 h [44].
Bacterial opsonisation
Bacteria were opsonised as previously described [39]. Briefly,
bacteria from an overnight culture were opsonised by incubation in
either the humanised anti-TSSPSAD antibodies or the non-specific
control antibody at a final concentration of 25 µg/ml (the highest
concentration that does not agglutinate the bacteria) at 37°C with
shaking for 30 min. The humanised anti-TSSPSAD antibodies share
the same variable regions (CAMPATH-1 [45]) that recognize the
human CD52 mimotope, but are of different human antibody
subclasses (either IgG1, IgG2, IgG3, or IgG4 [46,47]). The non-specific
control antibody used in this study is the recombinant human Fog-1
IgG1 [47] antibody that recognizes the human RhD antigen. Unbound
antibody was removed by extensive washing. Effective opsonisation
was visualized by fluorescence microscopy using Alexa Fluor 568
conjugated goat anti-human IgG (Invitrogen).
Immunofluorescence
Following opsonisation at 37°C with shaking for 30 min with either
the humanised anti-TSSPSAD antibodies or the non-specific control
antibody at a final concentration of 25 µg/ml, unbound antibody was
removed by washing. The opsonized bacteria were then labeling with
Alexa 568 conjugated goat anti-human IgG and visualized by
fluorescence microscopy.
Infection of THP-1 cells with S. Typhimurium
Following opsonisation, the bacteria were added to the THP-1 cells
at multiplicity of infection (MOI) of 10:1 (bacteria: THP-1 cells) and
incubated for 45 min at 37 ºC [39]. The infected cells were then washed
five times with PBS. Any remaining extracellular bacteria were killed
by incubating the infected cells with fresh culture medium containing
100 μg/ml gentamicin for 1 h. This time point was taken as 0 h. For
time point 8 h, the medium was replaced with fresh medium
supplemented with 10 μg/ml gentamicin and the cells were incubated
at 37 ºC for another 8 h.
Determination of the number of visible intracellular viable
bacteria
Twelve hours prior to infection, THP-1 cells were seeded onto poly-
L-Lysine treated coverslips (Fisher Scientific). THP-1 cells were
infected with opsonised bacteria. At 0 h, THP-1 cells were fixed with
4% paraformaldehyde for 15 min before staining with mouse
monoclonal anti-O4 antibodies (Abcam) and subsequently with
secondary goat anti-mouse Alexa Fluor 405 antibody (Invitrogen). All
antibodies were diluted 1:1000 in 10% normal goat serum (Dako).
Coverslips were mounted onto Vecta bond-treated glass slides (Vector
Laboratories) with mounting medium (Vectashield, Vector
Laboratories) and viewed using a Leica DM6000B fluorescence
microscope. Intracellular bacteria were discriminated from
extracellular bacteria by the presence of GFP and the absence of
labeling by the mouse monoclonal anti-O4 antibodies. For
experiments exploring the percentage of infected cells and intracellular
bacterial load distributions, 450 infected host cells were counted for
each one of three repeats.
Determination of intracellular bacterial viable counts
At each time point, the infected THP-1 cells were harvested by
lysing with 0.1% Triton-X for 15 min. Viable bacterial colony-forming
units (CFU) in the lysates were determined by the pour plate technique
using LB agar.
Host cell cytotoxicity
Host cell death was determined using the Cytotox 96 non-
radioactive cytotoxicity assay (Promega) according to manufacturer’s
protocol. The assay quantifies the amount of the cytosolic enzyme,
lactate dehydrogenase (LDH), released into the supernatant when the
membrane integrity of the cells was compromised as a result of cell
death.
Statistical analysis
All sets of experiments were performed as three independent
biological replicates (n=3). For determination of intracellular viable
bacterial counts and cell cytotoxicity, each independent set of
experiment was carried out in technical duplicate. Comparisons
between means were conducted using the paired Student’s t-test. We
considered every possible paired combination between groups and
controlled for the familywise error rate using a Holm-Bonferroni
correction. P value of <0.05 is considered to be significant. The data
described in this study are all statistically significant.
Results
Targeting flagella with antibodies can enhance phagocytosis of S.
Typhimurium by human cells
To examine whether antibodies that bind flagella can modulate
bacterial uptake by human phagocytic cells, we used an approach that
involves opsonisation of bacteria with recombinant humanised IgGs
followed by the addition of the opsonised bacteria to the human
phagocyte THP-1 cell line in vitro. We generated a recombinant S.
Typhimurium LDV321-GFP strain where we inserted the CD52
mimotope TSSPSAD into FliC, allowing targeting by a panel of
humanised anti-TSSPSAD antibodies with identical antigen-binding
V-regions and different IgG constant regions (IgG1, IgG2, IgG3 and
IgG4). Following a 45 min exposure to the opsonised bacteria, THP-1
cells were incubated for 1 h with culture medium containing 100 μg/ml
of gentamicin to kill any extracellular bacteria. This is indicated as time
point 0 h. We used the percentage of infected cells and the numbers of
intracellular bacteria per infected cell as robust parameters to
determine the effect of anti-flagella antibodies on bacterial uptake.
Opsonisation with specific antibodies that target S. Typhimurium
flagella resulted in a higher percentage of infected cells (Figure 1A), as
compared to the non-specific control human IgG1 antibody.
Comparing among the different antibodies, the percentages of infected
cells were statistically different between all the IgG subclasses; the
highest percentage was observed when the bacteria were opsonised
with IgG3, followed by IgG1, IgG4 and IgG2. We then studied the
effects of opsonisation on the intracellular bacterial loads. We
determined the number of visible intracellular bacteria per infected
cell by immunofluorescence. Extracellular bacteria were identified by
immunolabelling with mouse monoclonal anti-O4 antibodies, while
intracellular bacteria were identified by the presence of GFP and the
absence of the mouse monoclonal anti-O: 4 antibody labeling. When
the bacteria were opsonised with anti-TSSPSAD antibodies, we
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observed bacterial loads per phagocyte skewed towards higher
intracellular densities (Figure 1B), as compared to the non-specific
control antibody. Comparing among the different antibodies, the
percentage of infected cells containing more than three bacteria was
the highest when we used anti-TSSPSAD IgG3 antibodies to opsonize
the bacteria (50%), followed by IgG1 (38%), IgG4 (32%) and IgG2
(22%). We considered every possible paired combination between the
different antibody groups and controlled for the familywise error rate
using a Holm-Bonferroni correction. The differences for all
combination pairs of antibody (either with control isotype or with
other isotype) were statistically significant.
Antibody binding to flagella can enhance the reduction in
intracellular numbers of S. Typhimurium within human phagocytes
We have shown that antibodies targeting the flagella of S.
Typhimurium via the TSSPSAD mimotope can enhance the uptake of
S. Typhimurium by phagocytes. Next, we examined the effect of
flagella-targeting antibodies on the numbers of viable intracellular
bacteria. To explore this, we compared the intracellular viable bacterial
counts from infected THP-1 cell lysates at 0 h and at 8 h post infection
(p.i.). This was determined by counting the numbers of viable
intracellular bacteria in the infected THP-1 lysates at both time points
by plating on agar.
Opsonisation with all subclasses of anti-TSSPSAD antibodies
resulted in higher numbers of viable intracellular bacteria at 0 h p.i., as
compared with the non-specific control antibody (Figure 2A).
Comparing among the different antibodies, opsonisation with IgG3
resulted in the highest number of intracellular bacteria, followed by
IgG1, IgG4 and IgG2 with statistically significant differences between
all subclasses. At 8 h p.i., we observed lower intracellular viable
bacterial counts for the bacteria opsonised with any of the antibodies,
as compared with the counts at 0 h p.i. (Figure 2B). At 8 h p.i., the
intracellular viable bacterial counts were the lowest in the cultures
infected with bacteria opsonised with anti-TSSPSAD IgG3, followed by
IgG1, IgG4, IgG2 and lastly, non-specific control antibody. We
confirmed that the lower viable bacterial counts observed at 8 h p.i.
were not due to a higher level of death of the infected THP-1 cells,
which would result in exposure of the bacteria to the extracellular
antibiotic (Figure S3). After 8 h of infection, opsonisation with IgG3
resulted in the lowest percentage of host cell death, followed by IgG1,
then by IgG4 and non-specific control antibody, and lastly by IgG2. It
is possible that, due to the higher efficiency in bacterial killing with
IgG3 opsonisation, there is lower host cell death. At 0 h p.i., no
significant levels of host cell death were observed.
We also calculated the magnitude of the reduction in intracellular
bacterial numbers as the difference in the intracellular viable counts at
0 h and 8 h p.i. Opsonisation with specific antibodies targeting the
flagella resulted in a greater reduction in the intracellular viable
bacterial counts (Figure 2C), as compared to the non-specific control
antibodies. When the bacteria were opsonised by anti-TSSPSAD
antibodies, we observed a greater reduction in the intracellular viable
bacterial counts with IgG3, followed by IgG1, IgG4 and IgG2.
Figure 2: Viability of intracellular bacteria following time course
infection of S. Typhimurium opsonised with antibodies targeting
the bacterial flagella. THP-1 cells were infected with S.
Typhimurium opsonised with anti-TSSPSAD antibodies or control
IgG. Following an hour incubation with culture medium containing
100 µg/ml gentamicin to kill extracellular bacteria, the cells were
incubated with fresh culture medium containing 10 µg/ml
gentamicin, this is termed 0 h. For the time point 8 h, the cells were
incubated for another 8 h. The number of culturable intracellular
bacteria (viable count) recovered from THP-1 cell lysate at (A) 0 h
and (B) 8 h were determined. The horizontal lines in the graph
represent the mean viable bacterial counts. (C) The reduction in the
number of viable intracellular bacterial counts was defined as the
difference in the counts at 0 h and 8 h p.i. The horizontal lines in the
graph represent the mean reduction in the viable bacterial counts.
Each data point in the graph represents an independent set of
experiment.
Discussion
Surface proteins to be good vaccine candidates need to be
abundantly expressed, easily accessible to antibodies and can be easily
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purified in a conformation that retains immunogenicity. However
these criteria do not guarantee that targeting a surface protein results
in efficient enhancement of phagocyte functions, one of the main
correlated of protection in invasive Salmonella infections. Therefore
functional data on the effect of antibody binding to candidate surface
antigens are essential for preclinical vaccine development. The
Salmonella flagellum is a main bacterial target, inducing efficient
antibody production upon infection [25-27]. Due to its surface
localization, repetitive epitopes along their structure, and TLR-5-
associated pro-inflammatory adjuvanticity, flagella can be considered
as good protein carriers for inclusion in conjugate vaccines against
iNTS. However, to date, it is has not been clear whether antibodies
against flagella can enhance opsonophagocytosis and killing of the
bacteria by human phagocytes.
The key findings of this study are that: i) targeting flagella with
antibodies enhances phagocytosis and subsequent reductions in
intracellular loads of viable bacteria; and ii) different isotypes of
human IgG differ in their ability to modulate phagocytosis and
reductions in intracellular bacterial numbers. Opsonisation resulted in
an increase in bacterial uptake, as observed with a higher percentage of
infected cells, higher bacterial numbers per cell, and a higher number
of viable intracellular bacterial counts at 0 h p.i. (as compared to the
non-specific control isotype). Following the initial phagocytosis event,
specific antibody opsonisation also resulted in a greater reduction in
the number of viable intracellular bacterial counts at 8 h p.i. (as
compared to the non-specific control isotype). The magnitude of this
reduction in the observed 8 h time frame is indicative of bacterial
killing by the host cells, although differences in the bacteriostatic
functions of phagocytes may also play a minor role in the observed
phenomena.
We found that the efficiency in mediating bacterial uptake and
reductions in intracellular bacterial numbers by IgG targeting the
flagella differs, depending on the IgG subclasses. IgG3 is more efficient
than IgG1, followed by IgG4 and then IgG2. For all studied parameters
of bacterial uptake (namely the percentage of infected cells, the
intracellular bacterial distribution and the viable intracellular bacterial
counts at 0 h p.i.), the increase of bacteria uptake was the greatest when
S. Typhimurium was opsonised with IgG3, followed by IgG1, IgG4 and
lastly, IgG2. We have observed the similar pattern between the IgG
subclasses in intracellular bacterial killing at 8 h p.i.. One possible
reason for the difference in the anti-bacterial killing ability between the
different isotypes is the difference in the molecular flexibility of the
different subclasses. The greater flexibility of the hinge region of IgG3
probably allows IgG3 to associate better with activating Fcγ receptors
such as FcγRI and FcγRIIA [46, 48, 49] to mediate efficient bacterial
uptake and the subsequent intracellular bacterial killing, possibly
hence resulting in lower host cell death at 8 h p.i.. In fact, Th1-
associated IgG3 has been shown to be more advantageous than the
other subclasses in other infection systems, where IgG3 is negatively
associated with progression of clinical diseases [50]. We have recently
demonstrated that Th1-associated murine IgG2a and IgG2b were the
most efficient isotypes at lowering Salmonella bacterial load in the
blood, liver and spleen in vivo following infection in mouse [51].
Taken together, this has implications in the formulation of the vaccine
and the design of the vaccination regimes as the data suggest that
formulations and regimes that induce a Th1 response that is
predominantly IgG3 antibody response could offer better protection
against NTS.
In conclusion, our findings serve as a proof-of-principle,
demonstrating that antibodies targeting flagella can enhance bacterial
phagocytosis and intracellular bacterial killing against S. Typhimurium
efficiently. Efficient uptake of the bacteria by phagocytic cells is
particularly important as this could lead to efficient clearance of the
bacteria from the bloodstream, and hence possibly reducing the
occurrence of NTS bacteremia. In addition, the efficient intracellular
bacterial killing by phagocytic cells is critical to containment of the
infection which could lead to a faster resolution of the disease. Other
studies have also illustrated a role for flagella in T-cell immunity and its
association with protection in mice [31,34,52,53].
Our study therefore support the notion that flagella-based vaccines,
either as purified subunit protein preparations or as flagella-
polysaccharide conjugates have the potential to be promising vaccine
candidates for protection against NTS.
We have previously shown that antibodies targeting OmpA [39] and
lipopolysaccharides (LPS) [51] can increase bacterial uptake and
eventual bacterial killing. It is therefore interesting to speculate that
combination vaccines eliciting the right IgG isotype profile against
ompA, flagella and LPS antigens, possibly also though carefully chosen
delivery systems, may have the potential of being highly protective
against iNTS infections.
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